Category: Health

Brainomix Multicenter Study Demonstrates Potential of Quantitative CT for Earlier Detection of Progressive Pulmonary Fibrosis (PPF)

OXFORD, UK and CHICAGO, Oct 21, 2026 – Brainomix, a leading medtech company specializing in AI-powered imaging tools for lung disease and stroke, today announced the publication of new data from the REVISE PPF multicenter observational study demonstrating the potential of quantitative CT to help clinicians identify radiological evidence of progressive pulmonary fibrosis (PPF) significantly earlier than was possible using standard-of-care approaches.  With additional insights supporting their assessment of disease progression and patient risk, clinicians could use quantitative CT data to complement their diagnostic and risk stratification assessments, support more informed and timely treatment decisions, and potentially improve patient outcomes.

Published in The Annals of the American Thoracic Society, the retrospective study  evaluated 509 patients with fibrotic interstitial lung disease (ILD) across three specialist US centres: the University of Chicago, Weill Cornell Medicine and the University of Alabama at Birmingham. Researchers used Brainomix e-Lung, an FDA-cleared and CE marked AI-powered quantitative CT tool, to assess objective imaging outputs. The authors were able to relate their findings to ILD disease burden and pulmonary fibrosis progression.

Using Brainomix e-Lung quantitative CT measures, the researchers identified radiological progression an average of 16 months before the clinical PPF diagnosis, and up to 28 months earlier at one centre.  The analysis also identified radiological progression in a substantial proportion of patients who had been categorized as clinically stable, highlighting the potential for clinicians to use quantitative CT insights to identify previously unrecognized progression of pulmonary fibrosis in patients who may benefit from earlier treatment.

The study demonstrated how clinicians could derive valuable prognostic insights through their use of quantitative CT outputs. Specifically, a high baseline weighted reticulovascular score (WRVS) was associated with an increased risk of future PPF, while a 1.5% change in total disease extent on serial CT scans was associated with increased mortality. As current treatments can slow but not reverse lung function decline, these additional quantitative CT insights could enable clinicians to identify patients at greatest risk earlier, supporting more timely treatment decisions at a stage when more lung function may still be preserved.

Professor Ayodeji Adegunsoye, Pulmonologist at the University of Chicago Medicine and lead author of the study, said:

“This study provides important real-world evidence that quantitative CT can help clinicians uncover disease progression that may otherwise go unrecognized, including in patients who were considered clinically stable. Tools such as e-Lung have the potential to complement the information we gain from symptoms, lung function and conventional radiological assessment. This could help clinicians identify patients experiencing progressive pulmonary fibrosis earlier and make more informed decisions about monitoring and treatment.”

The study’s principal investigator, Professor Peter George, Consultant Pulmonologist at Royal Brompton Hospital and Senior Medical Director at Brainomix, said:

“The challenge with progressive pulmonary fibrosis is that by the time progression becomes clinically apparent, patients may already have experienced significant and potentially irreversible loss of lung function. These findings show that quantitative CT can reveal subtle changes in radiological features which can be challenging to detect through conventional assessment. The potential for clinicians to identify progression up to 28 months earlier is particularly striking and highlights the potential of integrating objective imaging measures into routine ILD care to support earlier diagnosis and treatment, with the aim of preserving lung function and improving outcomes for patients.”

The research was supported by funding from Boehringer Ingelheim, the leading biopharmaceutical company providing therapeutic options for interstitial lung disease (ILD). Martin Beck, Senior Vice President and Head of Therapeutic Area Inflammation, Boehringer Ingelheim, said:

“Lungs can’t wait, especially when a disease is progressive and the loss of lung function is irreversible. Recognizing progression as early as possible is therefore critical for people living with progressive pulmonary fibrosis. These findings provide valuable insights into how quantitative CT could complement existing clinical assessments and help identify signs of progression earlier. By supporting research such as this, we aim to deepen understanding of PPF and help advance more informed and timely care decisions for patients.”

Building on the findings from REVISE-PPF, Brainomix and Boehringer Ingelheim are continuing their collaboration through PROGRESS-PPF, a prospective, multicenter US study that will explore how AI-powered quantitative outputs could help clinicians enhance their understanding of PPF. Using e-Lung, the study will assess how quantitative CT could complement clinical assessments. Clinicians could use this data to gain new insights into disease progression and potentially support more informed treatment decisions.

This study has not been evaluated by FDA.

Better U and Evernow Partner to Transform Women’s Hormonal and Mental Health Care Through Menopause

New telehealth partnership pairs menopause specialists with integrative psychiatry to treat perimenopause and menopause symptoms, mind and body together

Holistic mental wellness provider Better U and menopause care company Evernow, available to women in all 50 states, have announced a strategic partnership to bring hormonal health and mental health care together for women across the United States.

The partnership combines Evernow’s specialized expertise in menopause and hormone therapy with Better U’sb integrative psychiatry, therapy and whole-body wellness services. Together, the two companies aim to close one of the biggest gaps in women’s healthcare by treating the physical and emotional sides of perimenopause and menopause as one connected experience.

The collaboration brings together Dr. Ellamarie Russo-DeMara, DO, MSCP, Medical Director at Evernow, and Dr. Janette Leal, MD, Executive Physician and Medical Director at Better U Clinical. Dr. Russo-DeMara is a board-certified OB/GYN with more than 30 years of clinical experience and has been a Menopause Society Certified Practitioner since 2009. Dr. Leal is a board-certified psychiatrist trained in internal medicine and psychiatry, with a geriatric psychiatry fellowship at Mayo Clinic.

Since its inception, Better U has focused on redefining mental healthcare across the United States through integrative and preventative telehealth care models. Both companies recognize that millions of women experience menopause symptoms for years with limited guidance, support, or access to specialized care, and share a goal of bringing modern, accessible women’s healthcare to a generation who’ve historically been overlooked.

Dr. Russo-DeMara’s approach centers on comprehensive, patient-focused treatment that combines evidence-based medicine with education, empathy, and holistic support. Her commitment is also deeply personal, having experienced early menopause following chemotherapy treatment for breast cancer.

Dr. Russo-DeMara, Medical Director at Evernow, said: “Going through menopause after chemotherapy showed me how disorienting these changes can be, even for someone who treats them for a living. I kept thinking about the women who don’t have that knowledge and are trying to make sense of it alone. That thought has shaped my work ever since.

“We’ve always believed menopause care should reach beyond hormones. Women in perimenopause and menopause are one of the most underserved populations in medicine, and too many are dismissed, misdiagnosed, or sent home with a prescription and no one ever looking at their hormones. Partnering with Better U lets us care for the whole woman, her hormones, her mood, her sleep and her sense of self, with a team that works together.”

Hormonal health is increasingly recognized as a major yet often overlooked factor in women’s mental health, contributing to perimenopause and menopause symptoms such as anxiety, depression, insomnia, irritability, and brain fog.

Dr. Leal, Executive Physician and Medical Director at Better U Clinical, added: “As a psychiatrist, I see this every week. A woman in her forties comes in with new anxiety, broken sleep and brain fog, convinced she’s losing herself. Very often the biology tells a different story. Estrogen helps regulate serotonin and dopamine, and a progesterone byproduct called allopregnanolone acts on the same calming GABA receptors that help us sleep. When those hormones start to swing in perimenopause, the brain feels it.

“Too many of these women were told it was stress or just getting older. Giving them the real explanation changes everything. Once a woman understands what’s happening in her body, the shame lifts and she can start working with her body instead of against it.

“This partnership pairs psychiatry with deep menopause expertise, so we can finally treat mind and body as the connected system they’ve always been.”

Founder of Better U, Derek Du Chesne, said: “Every woman deserves to be heard the first time she asks for help. I’m deeply grateful to partner with Evernow, Dr. Leal and Dr. Russo-DeMara to raise the standard of care by supporting mental and physical health together, and to bring that care to women wherever they live.”

Better U aims to redefine preventative women’s healthcare through innovations including advanced hormone monitoring, helping shift care from reactive treatment to proactive monitoring and prevention.

Through the partnership, women in perimenopause and menopause who are living with depression or anxiety that hasn’t improved with other treatments can also be evaluated for Better U’sat-home ketamine therapy. Each patient is screened by a licensed psychiatric clinician, and when clinically appropriate, ketamine is prescribed off-label and paired with integration coaching and ongoing support. Ketamine therapy does not treat menopause itself and is not right for everyone.

Sunlight, Nutrition and Outdoor Play Key to Building Strong Bones in Children: KIMS Doctors

By Dr. Roshan Kumar Jaiswal, Consultant Paediatric Orthopaedic Surgeon & Complex Trauma Surgeon Specialist KIMS Hospitals, Secunderabad

Adequate sunlight, balanced nutrition and regular physical activity are essential for healthy bone development in children, the Department of Orthopaedics at KIMS Hospitals, Secunderabad, said on the occasion of World Child and Bone Day 2026. The hospital highlighted the importance of preventing vitamin D deficiency and promoting healthy childhood habits at a time when children are increasingly spending long hours indoors using mobile phones, tablets and television screens.

Vitamin D plays a vital role in calcium absorption, bone mineralisation and muscle function. Inadequate levels can affect skeletal development and, in severe cases, lead to rickets, a condition characterised by soft and weak bones. Children with insufficient vitamin D may experience bone pain, muscle weakness, delayed growth or motor development, and difficulty keeping up with physical activities. However, these symptoms can have several causes and require appropriate medical evaluation.

The hospital emphasised that regular outdoor play, along with a nutritious diet, can contribute significantly to children’s overall health. Activities such as running, cycling, playing outdoor games and participating in age-appropriate sports help strengthen bones and muscles while supporting physical fitness and healthy development.

Sunlight enables the skin to produce vitamin D, although the amount produced varies depending on skin pigmentation, season, time of day, geographical location, clothing and other factors. As excessive ultraviolet radiation can damage the skin, children should receive sensible sun exposure without allowing their skin to burn. There is no single exposure duration that is appropriate for every child. Parents should follow locally appropriate sun-safety guidance and seek medical advice if they suspect vitamin

D deficiency.

A balanced diet is equally important for growing children. Milk, curd, cheese and other calcium-rich foods support bone health, while eggs and oily fish provide dietary vitamin D. Fortified milk, plant-based beverages, breakfast cereals and other fortified products can also contribute, depending on their nutritional content. Green leafy vegetables, pulses, nuts and seeds provide additional nutrients needed for growth. Children following vegetarian or vegan diets may require particular attention to vitamin D and calcium intake.

The hospital advised parents not to overlook persistent bone or joint pain, muscle weakness, unusual fatigue or concerns about a child’s growth and physical development. While these symptoms do not necessarily indicate vitamin D deficiency, timely consultation with a paediatrician can help identify the underlying cause. Vitamin D testing and supplementation should be considered when clinically indicated, with doses determined by a qualified healthcare professional rather than administered indiscriminately.

The Department of Orthopaedics at KIMS Hospitals, Secunderabad, urged parents to establish healthy routines at home by encouraging daily outdoor activities, limiting unnecessary recreational screen time, providing balanced meals and ensuring adequate sleep. Regular physical activity and appropriate nutrition during childhood help lay the foundation for stronger bones and better musculoskeletal health later in life.

The hospital’s message for World Child and Bone Day 2026 is simple: “Healthy Food, Happy Play, Strong Bones All the Way.” By making outdoor play and healthy eating part of everyday life, families can help children build stronger bones and enjoy a healthier childhood.

Can Exercise Worsen Arthritis? The Right Way to Stay Active with Joint Pain

By  Dr. Anirudh Maslekar– Attending Consultant – Rheumatology, KIMS Hospitals, Mahadevapura, Bengaluru.

For people with arthritis, working out might seem quite scary. It might appear counterproductive due to joint pain, stiffness, and inflammation, which may lead to avoiding physical activity. But it should be mentioned that proper exercise does not harm arthritis and is rather an essential component of arthritis management.

Arthritis, especially osteoarthritis, may impair joints in their ability to move freely. Over-straining, high-impact exercise, as well as improper exercises, may intensify symptoms. However, light exercises improve flexibility and decrease stiffness of the joints.

Why is exercise important for people with arthritis?

Engagement in physical exercises assists in maintaining good joint function through building the muscles that cushion shock absorption and stabilisation of the joint. Physical exercises can also aid in improving balance and decreasing fall risks, maintaining a healthy weight, and improving cardiac functions. Maintaining a healthy body weight is particularly important for individuals suffering from osteoarthritis in the knee and hip joints, as it minimises mechanical stress on the joints.

Physical exercises can also assist in decreasing morning stiffness and making daily activities such as walking, stair climbing, and rising from sitting down easier. What is important is to select the exercises that match one’s individual condition, fitness level, and pain threshold.

Which exercises are best for arthritis?

Low-impact activities are generally a good starting point. Walking on even surfaces, swimming, water-based exercises and cycling can improve endurance without placing excessive stress on the joints. Gentle range-of-motion exercises help maintain flexibility, while appropriate strength-training exercises build muscle support around affected joints.

Yoga, tai chi and guided stretching may also improve balance, mobility and body awareness. However, movements should be modified if they cause discomfort, and people with significant pain or mobility limitations should seek guidance from a healthcare professional or physiotherapist before beginning a new routine.

World Food Day: Rising Food Adulteration Concerns Put Odisha’s Safety Checks Under Scrutiny

Bhubaneswar, Oct 16: As the world observes World Food Day, concerns over food adulteration in Odisha are once again drawing attention to the safety of everyday food products, from milk, chhena and paneer to fruits, vegetables and popular street foods.

 Representational Image

Repeated raids by food safety officials in Bhubaneswar and other parts of the state have resulted in the seizure of suspected adulterated products. However, questions remain over how effectively enforcement measures are tackling the problem at its source and whether inspections are sufficiently regular across the food supply chain.

The issue has assumed particular significance following several operations targeting suspected fake dairy products and the use of chemicals for fruit ripening.

6,238 Food Samples Collected in Five Years

According to data cited by the Food Safety Department, officials collected 6,238 food samples during inspections at hotels, sweet shops, restaurants and other establishments in Bhubaneswar over the past five years.

Cases were reportedly registered against 460 people in connection with alleged food adulteration, while fines totalling Rs 5.40 lakh were collected.

Although these figures indicate enforcement action, concerns persist over whether the existing measures are sufficient to deter violations and prevent unsafe products from reaching consumers.

The challenge, observers say, extends beyond conducting raids and imposing penalties to identifying the sources of adulteration and ensuring compliance at every stage, from production and transportation to retail sale.

Suspected Adulteration of Chhena and Paneer Raises Concerns

The repeated seizure of suspected adulterated chhena and paneer has put dairy products under particular scrutiny in the state capital.

Milk is sold through tankers at several locations in Bhubaneswar, with vendors claiming that their supplies come from dairy farms and nearby villages. The milk is subsequently used to prepare products such as chhena and paneer for sale.

However, questions have been raised about the regular testing of milk supplied through these channels and the quality of the dairy products made from it.

The recent enforcement drives have renewed calls for closer monitoring of dairy supply chains, including checks on the origins of raw materials and the conditions under which products are manufactured and stored.

Chemical Fruit Ripening Comes Under Scanner

Food safety concerns are not confined to dairy products. The use of chemicals and artificial colours to improve the appearance or preserve the freshness of fruits, vegetables, fish and dried fish has also attracted attention.

Last month, food safety officials raided more than 30 banana warehouses in Bhubaneswar’s Bapuji Nagar, Ashok Nagar and Budha Nagar areas. During the operation, officials seized ethephon used for fruit ripening and destroyed more than one quintal of bananas.

The operation highlighted the need for continued monitoring of fruit storage facilities and markets to prevent the improper use of ripening agents.

Regular inspections are also considered important at roadside food stalls and other eateries, particularly during the festive season, when demand for prepared foods and fresh produce tends to rise.

Street Food Hygiene Also a Concern

Popular street foods such as gupchup, momos, chaat and chowmein are widely consumed across Bhubaneswar. Their popularity has also brought attention to questions surrounding hygiene, food handling and the quality of ingredients used by vendors.

Consumers’ safety depends not only on the quality of raw materials but also on proper storage, clean preparation areas and hygienic handling practices.

Regular checks at markets, restaurants and roadside stalls are therefore important to identify potential violations before they pose risks to the public.

Doctor Calls for Greater Food Safety Awareness

Dr Sudam Sarangi, an oncologist at SUM Hospital, stressed the importance of public awareness about food safety. He cautioned against consuming food containing harmful chemicals and artificial colours and advised people to pay attention to the quality of products they purchase.

He also recommended eating fresh fruits and undergoing regular health check-ups.

Health experts generally emphasise that consumers should buy food from reliable sources, wash fruits and vegetables thoroughly and avoid products that appear suspicious. However, identifying adulteration is not always possible through appearance alone, making effective testing and enforcement essential.

Officials Continue Raids Against Adulteration

Food Safety Officer Satyajit Patel said officials were regularly conducting raids at shops selling chhena and paneer. He added that fines were being imposed and traders were being warned against violations.

According to the report, 18 special drives have been conducted across Odisha to curb adulteration in chhena and paneer.

While the department has continued its enforcement efforts, a major challenge remains ensuring that inspections are sustained and that action extends beyond retail outlets to the manufacturing and distribution networks supplying the products.

Stronger Monitoring Needed to Protect Consumers

The concerns emerging on World Food Day underline the importance of a comprehensive approach to food safety in Odisha. Regular inspections, laboratory testing, effective penalties and closer monitoring of production and distribution channels are crucial to preventing adulterated food from entering the market.

For consumers, the issue is immediate and personal: whether the food purchased from shops, markets and roadside stalls is safe to eat.

As enforcement agencies continue their drives, sustained monitoring and greater transparency will be essential to strengthen public confidence and ensure that food safety standards are upheld across the state.

BioLab Holdings Launches EmeraNova™ to Advance the Future of Tissue Restoration

Multiple therapies, 21 years with advanced prostate cancer

At 75, Malay Kumar Sarkar goes for morning walks and practises a little yoga every day — 21 years after being diagnosed with stage IV prostate cancer.

Over the years, his treatment has ranged from surgery and hormonal therapy to chemotherapy, radiotherapy and nuclear medicine, with doctors turning to different treatment options whenever the disease gained the upper hand. Sarkar has remained resolute, determined to keep fighting.

The north Calcutta resident retired in 2012 as a senior audit officer with the Accountant General, Bengal, and receives treatment under CGHS. He leads a normal life with his wife, a former Damodar Valley Corporation employee; their daughter lives in Sydney.

India had an estimated 40,071 new prostate cancer cases in 2024, according to the International Agency for Research on Cancer. Estimates for that year also ranked it second among cancers in Indian men aged 65 and above.

Following progression of the disease in 2025, Sarkar began lutetium-177 PSMA-targeted radioligand therapy, a nuclear medicine treatment that delivers radiation to PSMA-expressing cancer cells. Three of six planned doses have reduced bone disease, with PSA, a disease-monitoring marker, falling from around 1,000 to 0.65.

Orchiectomy (surgical castration) in 2005 reduced testosterone, which fuels prostate cancer. Hormonal therapy continued until 2012, followed by 13 chemotherapy cycles from 2013 and further hormonal treatment. Radiotherapy treated bone metastases in 2018–19 and the spine in 2025.

Dr Sanchayan Mandal, senior consultant, medical oncology, HCG Cancer Centre, Kolkata, has overseen his treatment since late 2023, using novel hormonal therapies, including abiraterone and enzalutamide, in different treatment sequences as the disease evolved. He has also prescribed denosumab to help prevent bone complications. “Fitness and functional ability, rather than age alone, guide our treatment choices,” he said.

“Mr Sarkar’s journey shows why continuity of care and access to evolving treatments matter. Our goal is to give patients more years and more life within those years,” said Dr Rupali Basu, Regional Business Head (East & AP), HCG Cancer Hospitals.

Brainomix and Pulmonary Fibrosis Foundation Partner to Bring Patient Perspectives to AI-Powered Pulmonary Fibrosis Care

OXFORD, UK and CHICAGO, October 14^th, 2026 – Brainomix, a leading medtech company specializing in AI-powered imaging tools for lung disease and stroke, today announced a new partnership with the Pulmonary Fibrosis Foundation (PFF) to bring the voices of patients and caregivers into exploring how AI-powered imaging could support the care of people living with pulmonary fibrosis (PF) and other fibrotic interstitial lung diseases (ILD).

The partnership will focus on understanding patients’ perspectives when e-Lung quantitative CT analysis is incorporated into clinicians’ assessment workflow. The research will explore how access to objective quantitative CT metrics could enhance clinicians’ understanding of changes in disease over time, while examining how these insights are experienced and understood by patients. The initiative will also explore how these imaging insights could support more informed conversations between patients and their healthcare teams, including discussions around treatment decisions.

Brainomix 360 e-Lung is an FDA-cleared, CE-marked AI-powered image analysis tool that provides automatic quantifications and visualizations of radiographic features in lung CT scans. Clinicians can use these outputs to aid in their diagnostic assessment of lung diseases.

With its deep connection to the PF and ILD community and extensive expertise in patient education, research and care, the PFF is uniquely positioned to help guide this initiative. The Foundation will draw on its patient and caregiver community and its understanding of both the clinical and lived experience of pulmonary fibrosis, helping ensure patient perspectives remain central to the programme. Through its Care Center Network, the PFF also connects medical centers with expertise in diagnosing and treating fibrotic lung diseases and in patient-oriented research.

The programme is part of PROGRESS-PPF, a broader research initiative between Brainomix and Boehringer Ingelheim, exploring the potential of quantitative CT imaging tools to provide objective metrics that support clinicians in their assessment of disease progression in patients with progressive pulmonary fibrosis. The new collaboration with the PFF builds on that work by bringing the patient perspectives to the forefront, exploring how these imaging insights can support meaningful conversations between patients and clinicians.

“Patients are at the heart of everything we are trying to achieve with e-Lung,” said Dr. Michalis Papadakis, CEO and Co-Founder of Brainomix. “While our technology can provide new imaging tools for lung disease, we need to understand how those tools inform clinical understanding and how that information is communicated to and understood by the people living with the disease. Our partnership with the Pulmonary Fibrosis Foundation will help us listen directly to patients and caregivers and explore how AI-powered imaging tools can support greater understanding, communication and shared decision-making.”

The partnership will explore what patients want to know about their disease, how they respond to visual and quantitative outputs, and where e-Lung may provide the greatest value across their care. It will also explore how clinician imaging-derived insights could support conversations with patients about whether to start, continue or change treatment, particularly when changes in disease may not be evident from symptoms alone.

“People living with pulmonary fibrosis and their caregivers bring an essential perspective to the development of new approaches to understanding and managing this disease,” said Scott Staszak, President and CEO of the Pulmonary Fibrosis Foundation. “The PFF is deeply connected to the PF and ILD community and has a long-standing commitment to advancing research, education and care. We are pleased to partner with Brainomix to bring that patient voice and expertise into exploring how AI-powered quantitative imaging tools can be used in care. By listening directly to the community, we can better understand what information patients find valuable and how it can support conversations with their healthcare teams.”

The partnership reflects Brainomix and PFF’s shared commitment to further advancing a patient-centred approach to pulmonary fibrosis care, where new technologies are developed and evaluated with a clear understanding of the needs, experiences and priorities of the people they are intended to serve.

Rare Two-Headed Baby Born at Berhampur’s MKCG Medical College, Newborn Under Close Observation

A woman from Kandhamal district has delivered a baby with two heads and one body at MKCG Medical College and Hospital in Berhampur. The newborn has been admitted to the Special Newborn Care Unit, where doctors are closely monitoring the baby’s condition.

 Representational Image 

Berhampur, Oct 13 (UDN): A rare birth has been reported at MKCG Medical College and Hospital in Berhampur, Odisha, where a woman from Kandhamal district gave birth to a baby with two heads and one body.

According to reports, the newborn has one body and one heart, with two heads. The baby is currently receiving medical care at the hospital’s Special Newborn Care Unit (SNCU), where a medical team is keeping the condition under close observation.

The unusual case has drawn attention because of the rarity and medical complexity associated with congenital conditions involving the development of two heads.

Newborn Under Close Medical Observation

Following the birth, the baby was admitted to the advanced newborn care facility at MKCG Medical College and Hospital.

Doctors are reportedly monitoring vital health parameters, including breathing, heart rate and other essential indicators, to assess the newborn’s condition and provide appropriate care.

The medical team is continuing to observe the baby closely. Further details about the newborn’s condition and prognosis have not been provided in the available report.

What Is Craniopagus Parasiticus?

The condition has been identified in reports as craniopagus parasiticus, an extremely rare congenital abnormality associated with an additional head attached to another individual’s skull.

However, the precise classification of a two-headed birth depends on the baby’s anatomy, including how the skulls, brains, blood vessels and other structures are connected. A definitive diagnosis would require detailed medical evaluation.

Such cases are medically complex and require specialised assessment to understand the anatomy involved and determine the appropriate course of treatment.

Doctors Monitoring the Baby’s Condition

The newborn remains under medical supervision at MKCG Medical College and Hospital, with doctors monitoring vital signs and providing the necessary care.

The baby’s current clinical status, the detailed findings of medical examinations and the long-term prognosis remain unclear based on the information available so far.

Further updates from the hospital authorities may provide greater clarity on the newborn’s condition and the treatment being considered.

BMC Destroys 60 Kg of Stale Food in Bhubaneswar Eateries During Festive Season Raids

Bhubaneswar, Oct. 12 (UDN): The Bhubaneswar Municipal Corporation (BMC) has intensified its food safety enforcement drive ahead of the festive season, carrying out inspections at hotels and restaurants in the Patia area to ensure that customers are served safe and hygienic food.

 Representational Image 

During Monday’s raids, officials inspected food items at several establishments and destroyed stale and unfit food found during the operation. The drive aims to prevent unsafe food from reaching consumers as visits to eateries increase during the festive period.

60 Kg of Food Destroyed

BMC Food Safety Officer Satyajit Patel said around 60 kg of food had been destroyed so far as part of the enforcement campaign.

He said inspections were being conducted to identify stale and unhygienic food, with fines imposed on establishments found violating food safety requirements. Officials are also issuing warnings, while repeated or serious violations could lead to establishments being sealed.

The department is continuing its monitoring of hotels and restaurants to ensure that food served to the public meets basic hygiene and safety standards.

Strict Action Against Violations

With the festive season underway, the civic body has stepped up surveillance of food outlets to protect consumers from food that may be unsafe for consumption.

Alongside inspections and enforcement, officials are also raising awareness about food safety among the public and food business operators.

Patel said the raids would continue in the coming days, with the department maintaining vigilance over eateries across the city.

The intensified drive is intended to strengthen food safety compliance and ensure that residents and visitors can enjoy festive meals without compromising their health.